Header cover image

French (CAC) Pharma Industry Analysis

UpdatedJan 30, 2023
DataAggregated Company Financials
Companies8
  • 7D-1.3%
  • 3M1.8%
  • 1Y-4.4%
  • YTD-2.0%

Over the last 7 days, the Pharma industry has dropped 1.3%, driven by a pullback from Sanofi of 1.3%. Overall the industry is down 4.4% in 12 months. Looking forward, earnings are forecast to grow by 11% annually.

Industry Valuation and Performance

Has the French Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 30 Jan 2023€125.4b€50.7b€7.4b18.7x17x2.5x
Wed, 28 Dec 2022€127.7b€50.7b€7.4b17.3x17.4x2.5x
Fri, 25 Nov 2022€123.8b€50.7b€7.4b17.4x16.8x2.4x
Sun, 23 Oct 2022€116.3b€48.4b€7.6b16.5x15.3x2.4x
Tue, 20 Sep 2022€114.8b€48.4b€7.6b17.8x15.1x2.4x
Thu, 18 Aug 2022€117.3b€48.2b€7.6b23.7x15.5x2.4x
Sat, 16 Jul 2022€139.8b€46.3b€7.5b23.4x18.7x3x
Mon, 13 Jun 2022€134.7b€46.3b€7.5b21.8x18x2.9x
Wed, 11 May 2022€136.3b€45.4b€7.5b22x18.1x3x
Fri, 08 Apr 2022€139.8b€44.2b€7.1b23.2x19.8x3.2x
Sun, 06 Mar 2022€123.1b€44.1b€7.1b18.2x17.4x2.8x
Tue, 01 Feb 2022€128.9b€43.2b€7.0b18.9x18.4x3x
Thu, 30 Dec 2021€124.1b€43.2b€7.0b22.4x17.7x2.9x
Sat, 27 Nov 2021€120.1b€43.2b€7.0b21.1x17.2x2.8x
Mon, 25 Oct 2021€120.1b€42.3b€6.6b19.9x18.2x2.8x
Wed, 22 Sep 2021€116.0b€42.2b€6.6b24.2x17.6x2.7x
Fri, 20 Aug 2021€126.5b€42.2b€6.6b21.7x19.2x3x
Fri, 04 Jun 2021€120.3b€41.6b€12.9b16.4x9.3x2.9x
Mon, 08 Mar 2021€105.0b€41.9b€13.0b12.4x8.1x2.5x
Thu, 10 Dec 2020€116.7b€42.2b€11.6b20.3x10x2.8x
Wed, 02 Sep 2020€116.9b€42.3b€11.2b18.5x10.4x2.8x
Sat, 06 Jun 2020€118.5b€42.8b€3.5b24.4x33.7x2.8x
Tue, 10 Mar 2020€113.3b€42.2b€3.0b31x38.4x2.7x
Price to Earnings Ratio

39.9x


Total Market Cap: €117.8bTotal Earnings: €3.0bTotal Revenue: €42.2bTotal Market Cap vs Earnings and Revenue0%0%0%
French Pharma Industry Price to Earnings3Y Average 17.4x202120222023
Current Industry PE
  • Investors are relatively neutral on the French Pharmaceuticals industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PE ratio of 17.4x.
  • The 3-year average PS ratio of 2.8x is higher than the industry's current PS ratio of 2.5x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have grown 36% per year over the last three years.
  • Revenues for these companies have grown 6.3% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the French Healthcare industry?

FR Market1.41%
Healthcare-1.57%
Pharma-1.27%
Pharma-1.27%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
VIRP Virbac€281.002.6%
+€59.2m
-21.0%PE20x
BOI Boiron€43.452.5%
+€18.2m
7.5%PE14.9x
VETO Vetoquinol€88.001.7%
+€17.7m
-32.2%PE21.7x
MEDCL MedinCell€8.054.8%
+€9.3m
1.1%PS23.7x
ALTHX Theranexus Société Anonyme€1.951.2%
+€128.3k
-43.1%PS25.4x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

SAN

€89.55

Sanofi

7D

-0.4%

1Y

-3.5%

IPN

€99.05

Ipsen

7D

-0.9%

1Y

14.8%

ALTHX

€1.95

Theranexus Société Anonyme

7D

1.2%

1Y

-43.1%

VETO

€88.00

Vetoquinol

7D

1.7%

1Y

-32.2%

MEDCL

€8.05

MedinCell

7D

4.8%

1Y

1.1%

AB

€6.60

AB Science

7D

-2.7%

1Y

-26.4%

VIRP

€281.00

Virbac

7D

2.6%

1Y

-21.0%

ALDVI

€4.61

Advicenne

7D

-17.7%

1Y

-43.9%

MLGML

€0.03

Gour Medical

7D

-40.0%

1Y

-60.5%

ALMDP

€2.82

Medesis Pharma

7D

-5.1%

1Y

-38.5%